Status:

RECRUITING

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

Lead Sponsor:

David Sheyn

Conditions:

Interstitial Cystitis

Painful Bladder Syndrome

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary ...

Detailed Description

Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/or discomfort associated with urinary f...

Eligibility Criteria

Inclusion

  • Patients 18 years of age or older
  • Female
  • English Speaking
  • Diagnosis of IC/PBS
  • Have failed at least one prior treatment for IC/PBS

Exclusion

  • Patients less than 18 years of age
  • Unable to provide consent
  • Non-English speaking
  • Patients with known anatomical malformations of the ureters, bladder, or urethra

Key Trial Info

Start Date :

July 24 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06096597

Start Date

July 24 2024

End Date

June 1 2026

Last Update

August 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals

Clevleand, Ohio, United States, 44106

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome | DecenTrialz